ORIX
IXNYSEUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $32.70 Prior regular-session close from the quote source.
- $33.05–$33.56 Regular-session low and high so far today.
- 247.0K Regular-session shares traded · Nov 11, 4:00 PM ET.
- Not yet confirmed The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
- $25.29–$42.39 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own IX if ORIX turns its insurance-like balance-sheet and diversified leasing/investment businesses into recurring fee & interest income, using a large cash buffer to fund higher-return acquisitions and steady shareholder distributions while underwriting credit risk tightly.
IX price history
Loading recent earnings…
Investment thesis
What must happen next
ORIX's diversified finance and asset-investment model causally converts balance-sheet capacity into recurring interest/fee revenue, so maintaining asset scale and deployment drives top-line growth.StrengtheningMateriality: High
FY2026 revenue = 1,504,029,000,000 JPY (annual) — an increase from FY2025 revenue = 1,352,263,000,000 JPY. If true, revenue growth will be steady and predictable and support dividends/returns; if false, growth will be lumpy and tied to one-off trading or asset sales.
Watch: A material rise in credit losses or impairments tied to ORIX's loan/lease portfolios (a macro-driven spike in delinquencies).
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY2026 revenue = 1,504,029,000,000 JPY (annual) — an increase from FY2025 revenue = 1,352,263,000,000 JPY.
Open source ↗ORIX's large cash/liquidity buffer gives it optionality to fund acquisitions, opportunistic asset purchases, and shareholder distributions without near-term external financing, preserving return-on-equity.StrengtheningMateriality: High
FY2026 cash = 1,451,099,000,000 JPY (instant) — up from FY2025 cash = 1,321,983,000,000 JPY. Holding a large cash buffer reduces funding risk and enables value-accretive M&A or buybacks; if the buffer falls or is consumed unprofitably, returns and dividends are at risk.
Watch: A large, value-destroying acquisition or series of acquisitions that materially depletes cash/reserves.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY2026 cash = 1,451,099,000,000 JPY (instant) — up from FY2025 cash = 1,321,983,000,000 JPY.
Open source ↗ORIX's ability to preserve returns depends on disciplined underwriting and provisioning; if underwriting weakens, impairments and credit losses will lead revenue and cash to deteriorate.HoldingMateriality: Medium
Operating income is a reported operating-level metric (historic filings include operating_income entries, though recent annual series in the provided data are limited). Preserved underwriting discipline sustains margins and cash generation; deterioration is a leading indicator of future operating losses and capital strain.
Watch: Macro recession producing higher-than-expected defaults in ORIX's lease/loan portfolios.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Operating income is a reported operating-level metric (historic filings include operating_income entries, though recent annual series in the provided data.
Open source ↗For the stock to outperform, ORIX must convert extra liquidity into higher-return uses (accretive M&A, higher-yield asset buys, or larger sustainable buybacks/dividends) that translate into revenue and cash generation above recent trends.HoldingMateriality: Medium
Revenue acceleration in FY2026 (1,504B JPY) versus FY2025 (1,352B JPY) shows the company can grow top-line when deployment and markets align. The market prices in stability; only better-than-historical deployment of capital (without raising credit risk) will expand multiples or accelerate EPS.
Watch: If cash is deployed into low-return or high-risk assets that later require impairments, the stock will re-rate down even if headline revenue grows.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Revenue acceleration in FY2026 (1,504B JPY) versus FY2025 (1,352B JPY) shows the company can grow top-line when deployment and markets.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
ORIX's diversified finance and asset-investment model causally converts balance-sheet capacity into recurring interest/fee revenue, so maintaining asset scale and deployment drives top-line growth. If true, revenue growth will be steady and predictable and support dividends/returns; if false, growth will be lumpy and tied to one-off trading or asset sales.
ORIX's large cash/liquidity buffer gives it optionality to fund acquisitions, opportunistic asset purchases, and shareholder distributions without near-term external financing, preserving return-on-equity. Holding a large cash buffer reduces funding risk and enables value-accretive M&A or buybacks; if the buffer falls or is consumed unprofitably, returns and dividends are at risk.
ORIX's ability to preserve returns depends on disciplined underwriting and provisioning; if underwriting weakens, impairments and credit losses will lead revenue and cash to deteriorate. Preserved underwriting discipline sustains margins and cash generation; deterioration is a leading indicator of future operating losses and capital strain.
For the stock to outperform, ORIX must convert extra liquidity into higher-return uses (accretive M&A, higher-yield asset buys, or larger sustainable buybacks/dividends) that translate into revenue and cash generation above recent trends. The market prices in stability; only better-than-historical deployment of capital (without raising credit risk) will expand multiples or accelerate EPS.
All standing thesis claims
Original report summary
ORIX turns its insurance-like balance-sheet and diversified leasing/investment businesses into recurring fee & interest income, using a large cash buffer to fund higher-return acquisitions and steady shareholder distributions while underwriting credit risk tightly.
Bull case and bear case
Bull case and bear case for Orix
Where the evidence on Orix stands: Holding on the latest evidence (Nov 12, 2026). Of its 4 thesis points, 2 strengthening and 2 holding.
Bull case: what the evidence supports
ORIX's diversified finance and asset-investment model causally converts balance-sheet capacity into recurring interest/fee revenue, so maintaining asset scale and deployment drives top-line growth.
ORIX's large cash/liquidity buffer gives it optionality to fund acquisitions, opportunistic asset purchases, and shareholder distributions without near-term external financing, preserving return-on-equity.
ORIX's ability to preserve returns depends on disciplined underwriting and provisioning; if underwriting weakens, impairments and credit losses will lead revenue and cash to deteriorate.
For the stock to outperform, ORIX must convert extra liquidity into higher-return uses (accretive M&A, higher-yield asset buys, or larger sustainable buybacks/dividends) that translate into revenue and cash generation above recent trends.
Bear case: what would count against it
A material rise in credit losses or impairments tied to ORIX's loan/lease portfolios (a macro-driven spike in delinquencies).
A large, value-destroying acquisition or series of acquisitions that materially depletes cash/reserves.
Macro recession producing higher-than-expected defaults in ORIX's lease/loan portfolios.
Thesis-Break Engine
Thesis-break watch · Orix
Loading the break-condition record for Orix.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedForeign issuer material report (6-K).
Orix filed an SEC report on 2026-11-09: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.
- MixedForeign issuer material report (6-K).
Orix filed an SEC report on 2026-11-05: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.
- MixedForeign issuer material report (6-K).
Orix filed an SEC report on 2026-10-27: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- A material rise in credit losses or impairments tied to ORIX's loan/lease portfolios (a macro-driven spike in delinquencies).
- A large, value-destroying acquisition or series of acquisitions that materially depletes cash/reserves.
- Macro recession producing higher-than-expected defaults in ORIX's lease/loan portfolios.
- If cash is deployed into low-return or high-risk assets that later require impairments, the stock will re-rate down even if headline revenue grows.
IX news
Loading headlines…
Financial statements
IX income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
IX: quick answers
- What is IX's short interest?
- As of October 30, 2026, 862,497 IX shares were sold short, up 0.1% from the count before. At the stock's average daily volume that is 4.7 days to cover. FINRA publishes the count twice a month. IX short interest history
- Have members of Congress traded IX?
- 3 trades in IX have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed IX trade
